射雕英雄传

一 |     

    The "flying lifebuoy" debuts during a water rescue drill in Hangzhou, East China's Zhejiang Province. Photo: Official WeChat account of the Hangzhou governmentA "flying lifebuoy" recently made its debut during a water rescue drill organized by police in Hangzhou, East China's Zhejiang Province, as the city explores multiple high-tech solutions to improve emergency response in water accidents. The device received praise from a Chinese Foreign Ministry spokesperson. 
According to a report posted on the official WeChat account of Hangzhou, an orange lifebuoy took off from the shore during the drill, flew toward a person who had fallen into the water, and landed on the water surface. Even when the person climbed onto it, the device remained stable and continued to float.
Minutes later, rescuers arrived and brought the person to safety. The lifebuoy then took off again and returned to its original location.
The device, officially called an AI intelligent flying rescue robot, is designed to provide rapid assistance in open waters where rescue boats may take time to arrive. Equipped with an autonomous navigation system, it can fly to people in distress, provide buoyancy support, and return automatically after completing its mission.
The drill featured multiple water rescue scenarios and tested several intelligent rescue technologies. Drones were used to drop inflatable lifebuoys above people in distress, which quickly inflate upon hitting the water to provide temporary buoyancy.
Another system combined an unmanned boat and drone for rescue operations in dangerous waters. The drone searches and locates people in need, while the boat navigates autonomously to assist the rescue. The drone can also provide lighting for nighttime searches, according to the report.
Chinese Foreign Ministry spokesperson Lin Jian highlighted in a social media post on August 14 that the AI-powered device is "technology that could help save lives."
Global Times
。    获悉，上海市人民政府办公厅印发《上海市战略性新兴产业发展“十五五”规划》。其中提到，加快具有重大知识产权价值的创新药培育开发，建立创新药发现遴选机制，加强AI模型对临床成功率等的辅助预判，推动高质量医疗和临床研究队列数据支撑创新药开发转化。重点发展：1.高临床价值创新药。推动AI技术在靶点挖掘、分子生成、药效模拟等环节赋能应用，支持多功能抗体、通用型细胞、蛋白靶向降解等新机制药物研究转化。

二 | 2.智能化高端医疗器械。

三 | 支持小型化质子放疗设备、柔性手术机器人等智能化高端医疗器械开发和关键器件材料攻关。3.高端医药研发和医疗服务。支持医药合同研发机构（CRO）搭建AI辅助药物开发模型和自动化实验室，推动合同生产机构（CDMO）加快连续流等先进工艺应用。提升国际医疗商保结算、就医流程的便利性。原文链接。